Everence Capital Management Inc Adma Biologics, Inc. Transaction History
Everence Capital Management Inc
- $1.59 Billion
- Q3 2024
A detailed history of Everence Capital Management Inc transactions in Adma Biologics, Inc. stock. As of the latest transaction made, Everence Capital Management Inc holds 28,580 shares of ADMA stock, worth $490,146. This represents 0.04% of its overall portfolio holdings.
Number of Shares
28,580Holding current value
$490,146% of portfolio
0.04%Shares
1 transactions
Others Institutions Holding ADMA
# of Institutions
319Shares Held
184MCall Options Held
917KPut Options Held
91.6K-
Black Rock Inc. New York, NY18.6MShares$320 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA18.1MShares$311 Million0.01% of portfolio
-
State Street Corp Boston, MA13MShares$223 Million0.01% of portfolio
-
Invesco Ltd. Atlanta, GA12.6MShares$216 Million0.05% of portfolio
-
Morgan Stanley New York, NY8.6MShares$147 Million0.01% of portfolio
About ADMA BIOLOGICS, INC.
- Ticker ADMA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 196,356,992
- Market Cap $3.37B
- Description
- ADMA Biologics, Inc., a biopharmaceutical company, engages in developing, manufacturing, and marketing specialty plasma-derived biologics for the treatment of immune deficiencies and infectious diseases in the United States and internationally. It offers BIVIGAM, an intravenous immune globulin (IVIG) product indicated for the treatment of primar...